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The compartmentalisation of proteins within membrane-bound, subcellular structures called organelles is a definingfeature of eukaryotic cells. The function of a protein can
often be inferred from its subcellular location and its availability
to interact with other biomolecules within its microenvironment.
A protein may exert multifunctional, context-specific roles if it
resides in different locations within a single cell, a process known
as “moonlighting”1. Dysfunctional protein localisation or the
disruption of dynamic shuttling events between subcellular niches
can underlie various pathophysiological processes and contribute
to disease progression2. Protein trafficking and translocation play
a major role in the innate immune response of mammalian cells3,
and although dysregulation of these events can contribute to an
infection and the development of inflammatory diseases, the
drivers of these processes remain incompletely characterised.
Lipopolysaccharides (LPS) derived from the outer membrane of
Gram-negative bacteria are some of the most potent activators of
the immune system. Toll-like receptor 4 (TLR4), the mammalian
receptor for LPS, plays a beneficial role in controlling bacterial
infections but is also a main driver of sepsis. It has recently been
estimated that there are 49 million cases of sepsis per year globally,
with 11 million sepsis-related deaths4, and sepsis is the most
common cause of death in people who have been hospitalised5. In
addition, Alzheimer’s disease, alcoholic liver disease, cardiovas-
cular disease and type 2 diabetes have all been associated with
systemic LPS exposure and subsequent inflammatory response6,7.
LPS induces a distinct pro-inflammatory response resulting in
activation of TLR4 signalling via MyD88-dependent and inde-
pendent (TRIF-dependent) pathways, with an elevation in pro-
inflammatory cytokines and Type 1 interferons (hereafter referred
to as IFNs), respectively8.
Previous studies have successfully used proteomics approaches
to either explore aspects of the innate immune response to LPS in
macrophages9,10 or to characterise individual subcellular regions
of interest following LPS-stimulation11,12. Despite these efforts,
the cell-wide mechanism underlying the LPS-driven response is
still not fully understood. Although assessing alterations in gene
and protein expression is certainly important, the dynamic pro-
cesses of protein trafficking and translocation may also underlie
many abnormal physiological processes. We, therefore, decided to
investigate subcellular protein translocation during the response
to LPS stimulation, using the human monocytic leukaemia cell
line THP-1, which is widely used in the immunology field and has
proven particularly difficult to transfect and image by micro-
scopy, due in part to its non-adherent morphology while in an
undifferentiated, monocytic state.
Non-imaging mass spectrometry (MS)-based spatial pro-
teomics methods provide an alternative yet orthogonal approach
to microscopy for the investigation of protein subcellular
localisation13,14. MS has provided a means of cataloguing the
components of purified organelles15,16, however, this approach
may be prone to false-positive assignments due to difficulties
associated with purifying organelles to homogeneity which have
similar physicochemical properties. Recent advances in the field
of spatial proteomics have taken a holistic approach to char-
acterise and quantifying protein subcellular localisation. These
methods provide a global overview of a cell population by
accurately pinpointing thousands of proteins to distinct sub-
cellular niches, enabling molecular annotation of whole organelles
without the need for organelle purification17–19. One of the
forerunners in this field is LOPIT—Localisation of Organelle
Proteins by Isotope Tagging20, and its more recent iterations,
hyperLOPIT (hyperplexed LOPIT)21–27 and LOPIT-DC (LOPIT
after Differential ultraCentrifugation)24,28. The hyperLOPIT
method combines extensive biochemical cell fractionation with
multiplexed high-resolution MS-based proteomics for the
simultaneous analysis of the steady-state distribution of thou-
sands of native proteins within a sample. Multivariate data ana-
lysis is conducted using the MS proteomics packages MSnbase29
and pRoloc30, which provide a robust framework for processing,
visualisation, and interrogation of spatial proteomics data as part
of the open-source, open-development Bioconductor31,32 suite of
R software33. Additional modalities for phenotype discovery34,35,
transfer learning from heterogeneous data sources36, assessment
of cluster separation as a data resolution metric37 and probabil-
istic classifiers such as Bayesian mixture modelling38 have
recently been integrated into the pRoloc pipeline.
HyperLOPIT provides a global snap-shot of an entire dynamic
cellular system in an unbiased and untargeted manner. This
methodology has previously been used for spatial mapping of the
E14TG2a mouse embryonic stem cell line21, the human U-2 OS
osteosarcoma cell line24,25, the yeast Saccharomyces cerevisiae22,23
and apicomplexan parasite Toxoplasma gondii27, with excellent
resolution. Adapting spatial mapping methods such as hyper-
LOPIT and LOPIT-DC to track relocalisation events in response
to perturbation or stimulation is now a major line of interest in
the field and will greatly improve our understanding of dynamic
biological processes and disease aetiology39.
In this work we present a high resolution, global interrogation
of the temporal and spatial proteome during an innate immune
response in THP-1 cells, making use of the enhanced resolution
of hyperLOPIT to capture protein relocalisation upon stimulation
with LPS. The resulting data are showcased in a freely available
interactive R Shiny application (http://proteome.shinyapps.io/
thp-lopit/).
Results
Temporal proteome analyses reveal a cell-wide pro-inflamma-
tory response in THP-1 cells during 0–24 h of LPS stimulation.
The experimental and computational workflows for this study are
outlined in Fig. 1. Functional biological processes can be inde-
pendently regulated both by changes in protein abundance and
also by protein trafficking and translocation. Therefore, it was
important to first assess the global proteomic landscape of the
THP-1 monocytic leukaemic cell line within our time frame of
interest. Total (unfractionated) cell lysates were collected at var-
ious time points following LPS stimulation (0, 2, 4, 6, 12, and
24 h) and processed for quantitative, MS-based proteomics ana-
lysis. 4292 proteins were reproducibly quantified in three biolo-
gical replicate experiments, at all 6 time points (Supplementary
Data 1, Supplementary Fig. 1a). A total of 311 proteins were
found to be altered in abundance during the time-course of LPS
stimulation, with statistical significance (adjusted p-value < 0.01
and log2FC > 0.6) (Supplementary Data 1). The functional effects
of these changes are outlined below.
The early phase response to LPS (2–6 h) involves activation of
classic pro-inflammatory mediators and an antioxidant
response. Interleukin 1-beta (IL1B) was the only protein found to
be significantly upregulated in expression by 2 h-LPS and
remained elevated in abundance throughout the 24 h time-course
(Figs. 2a, e). Upregulated cellular levels of IL1B correlated with
increased IL1B secretion into the cell supernatant, as measured by
ELISA (Fig. 2d). By 4 h-LPS, three additional proteins were
upregulated, all of which are characteristic of an early pro-
inflammatory IFN response (IFIT2, IFIT3, CXCL10) (Fig. 2b).
The increase in the intracellular levels of the chemokine CXCL10
coincided with its elevated secretion, as measured by ELISA
(Fig. 2d).
Thirty-two proteins were significantly altered at the protein
level by 6 h-LPS (Fig. 2c), 17 of which are known IFN-inducible,
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anti-microbial response proteins. Upregulation of PARP14 at 6 h-
LPS supports the existing evidence that PARP14 is strongly
induced by LPS stimulation and controls a subset of type 1 IFN-
inducible proteins40 including the heterodimers DTX3L–PARP941
and IFI35–NMI42, all of which were also found to be elevated in
abundance during the time-course.
The generation of reactive oxygen species (ROS) can also drive
a pro-inflammatory macrophage response upon LPS stimulation.
Fig. 1 Overview of the spatiotemporal experimental pipeline. a TMT labelling strategy for the temporal and the spatial MS proteomics analysis. Each
experiment was performed in triplicate. b Experimental and computational workflows.
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By 6 h-LPS, a proteome-wide response to increased intracellular
ROS was apparent, through the elevation of the anti-oxidative
superoxide dismutase 2 (SOD2), myeloid leukaemia cell differ-
entiation protein (MCL1) and haem-oxygenase-1 (HMOX1).
These findings agree with Widdrington et al.43, who demonstrated
that exposure of THP-1 monocytes to LPS resulted in a significant
increase in ROS production by 6 h, triggering the induction of
antioxidant defense, mitophagy and mitochondrial biogenesis
programmes.
There was concomitant downregulation of three proteins at the
6 h-LPS time-point, CLEC11A, a haematopoietic growth factor
that acts as a secreted cytokine during monocyte/macrophage
recruitment44, KDM4A, oxygen sensing histone demethylase, and
the tumour suppressor PDCD4.
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Delayed THP-1 response to LPS reveals an expansion in anti-
microbial immunity and the initiation of a regulatory anti-
inflammatory process. Twelve hours after the initial exposure to
LPS, 72 proteins were identified as having been altered in abun-
dance, with 64 upregulated and 8 downregulated (Fig. 2f, h). The
immune response at 12 h-LPS continued to be dominated by an
elevation in proteins known to be activated by LPS, including
CCL5 (RANTES), RIG-I (DDX58), OAS2 and IFIT5. There was
also evidence of the initiation of an anti-inflammatory process at
12 h-LPS with the increase in expression of NT5C3A, ABCA1,
IFI44L, SAMD9, and MARCKS, all of which have been shown to
inhibit the pro-inflammatory immune response. Interestingly,
THP-1 cells appear to have adapted to the prolonged LPS sti-
mulus at 12 h by modulating proteins that bind and transport
LPS. A reduction in the expression of very-low-density lipopro-
tein receptor (VLDLR) and elevation of phospholipid-transporter
ABCA1 was apparent by 12 h-LPS. VLDLR45 and ABCA146 have
been shown to control the import and export of LPS, respectively.
There was a significant reduction in the abundance of eight
proteins by 12 h-LPS, including the zinc finger protein GFI1,
known to regulate the LPS driven TLR4 response by antagonising
NFkB activity in THP-1 cells47. The proto-oncogene tyrosine
kinase receptor RET was also down-regulated by 12 h-LPS, which
was previously observed to be reduced in expression during
differentiation of THP-1 cells towards the macrophage lineage48.
Furthermore, the elevation of a classical marker of M1
macrophage differentiation, epithelial–stromal interaction protein
1 (EPSTI1)49 at 6 h-LPS, and the upregulation of intercellular
adhesion molecule ICAM1 at 12 h-LPS, further supports the view
that THP-1 cells are primed by 12 h-LPS to undergo a
polarisation towards a pro-inflammatory phenotype.
Cell cycle arrest, altered cellular morphology and upregulation
of proteins associated with antigen presentation and T cell
stimulation are apparent by 24 h of LPS exposure. The THP-1
proteome demonstrates a major alteration by 24 h-LPS, with 178
upregulated and 131 downregulated proteins (Fig. 2g). Monocyte
to macrophage maturation occurs upon LPS exposure and the
substantial change to the proteome at 24 h clearly reflects this
transition between these two phenotypes. We identified upregu-
lation of CD14, the main co-receptor for LPS which mediates
TLR4 signalling upon LPS binding, as well as several signalling
and scaffold molecules involved in the TLR4 response, including
SASH1, THEMIS2 and the scavenger receptor CD36. The IFN
response was sustained at 24 h-LPS, with the additional upregu-
lation of anti-microbial molecules such as OAS1, EIF2AK2,
TRIM14 and CMTR1. Maturation towards a pro-inflammatory
macrophage phenotype was also evident by the upregulation of
proteins associated with antigen presentation and peptide loading
at the endoplasmic reticulum (ER) (HLA-A HLA-B, B2M, TAP1,
TAP2) and T cell co-stimulation (ICAM1, ADA, CD40 and SPN).
The monocytic adhesion molecule ITGAX (CD11C) is known to
be down-regulated during the monocyte-to-macrophage
transition. Our proteomics data demonstrate a loss in ITGAX
expression at 24 h-LPS, suggesting that the process of macro-
phage maturation is underway at this time point. Macrophage
polarisation by 24 h is further supported by the upregulation of
PLEKHO2, which has previously been linked to macrophage
survival, differentiation and maturation in mice50.
A substantial number of downregulated proteins at 24 h-LPS
are associated with cell division, DNA replication, centrosomal,
microtubule and kinetochore regulation (Supplementary Data 2).
A reduction in cell cycle proteins corresponds to the previously
reported cell cycle arrest upon LPS stimulation of THP-1 cells51
and a reduced expression of the classic marker of cellular
proliferation, MKI67, was observed.
A number of molecules known to be involved in cytoskeletal
processes including the regulation of actin dynamics, extracellular
matrix (ECM) and cellular migration were altered in abundance
(Supplementary Data 2). Downregulation of lymphocyte-specific
protein (LSP1) was detected, which is a critical regulator of
actomyosin contractility and migration in primary
macrophages52. The proteoglycan serglycin (SRGN) was also
reduced and has been previously shown to decrease during the
monocyte-to-macrophage maturation of THP-1 cells53.
By 24 h, the response to LPS appears to be cellular-wide with
alterations in intracellular vesicular and endosomal trafficking,
autophagy-lysosomal machinery, and metabolic regulators (Sup-
plementary Data 2). LACC1 (FAMIN), a central regulator of the
metabolic function of macrophages, plays a role in inflammasome
activation, ROS production and bactericidal activity54. Compo-
nents of the inflammasome such as CASP1, CASP4 and Pyrin are
upregulated, which coincides with the continued secretion of
IL1B. Together, our results demonstrate a global response to LPS
stimulation in the THP-1 proteome over the course of 24 h,
which is distributed throughout the subcellular landscape and
coincides with the phenotypic switch from monocyte to
macrophage.
An overview of global proteomic changes using unsupervised
Bayesian clustering in combination with annotation enrich-
ment. The proteomic time-course series was modelled using a
Bayesian mixture model to capture clusters of co-regulated pro-
teins and temporal patterns of protein expression in response to
LPS. Replicate experiments were combined using multiple dataset
integration (MDI)55 where the number of clusters was auto-
matically inferred. Using this unsupervised approach, 1057 pro-
teins in the time-course series were assigned to 49 distinct clusters
(Supplementary Data 3) and Gene Ontology (GO) enrichment
analysis was used to identify overrepresented annotation terms
associated with each cluster (Supplementary Data 4). Of the
clusters, 17 were enriched for significantly overrepresented bio-
logical process (GOBP) related terms (adjusted p-value < 0.05),
providing a functional insight into the biological activities affec-
ted by LPS within 24 h of stimulation.
Fig. 2 Time-course of quantitative abundance changes in proteins during 24 h of LPS stimulation. a Volcano plots showing the abundance of all 4292
time-course proteins at 2 h, b 4 h, c 6 h of LPS stimulation. d Median quantitative values for intracellular proteomics abundance (red) and extracellular,
cytokine secretion levels as measured by ELISA (blue) for IL1B and CXCL10 expression (n= 3 biologically independent experiments). e Western blot
(n= 1) of IL1B expression in THP-1 lysates during 24 h-LPS stimulation. Molecular weight markers in kilodaltons (kDa). The same blot was stripped and re-
probed with anti-SQSTM1 for Fig. 6c. The same actin blot was therefore also used as a loading control. f Volcano plot demonstrating 72 proteins
significantly changed in abundance by 12 h-LPS. g Volcano plot demonstrating 309 proteins significantly changed in abundance by 24 h-LPS. h Heatmap of
the protein abundance for the 72 proteins significantly changed in abundance by 12 h-LPS during the time-course analysis. For all volcano plots proteins
that are significantly upregulated (FDR < 0.01, log2FC > 0.6) and downregulated (FDR < 0.01, log2FC < 0.6) are highlighted in red and blue, respectively.
Where relevant the top 15 most significantly changed proteins in each direction have been annotated with their corresponding gene name. The source data
are provided as a Source Data file.
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Six representatives upregulated (Fig. 3a) and six downregulated
(Fig. 3b) clusters are shown with corresponding GO annotation
enrichments (Fig. 3c–e). Temporal Clusters One (n= 46), Two
(n= 103) and Three (n= 87) all demonstrated an upregulated trend
throughout the time-course (Fig. 3a), occurring at an early (4–6 h),
mid (12 h) and late (24 h) stage, respectively. GO annotation
enrichment confirmed that Cluster One was significantly enriched
for the term “response to external biotic stimulus”, Cluster Two was
enriched for “innate immune response” and Cluster Three for
“endocytosis” (Fig. 3a). Clusters Four (n= 14), Five (n= 29) and Six
(n= 58) were also upregulated through the time-course and were
enriched for “interspecies interaction between organisms”, “tRNA
transport” and “intracellular protein transport”, respectively (Fig. 3c),
further supporting a role for intracellular trafficking and translocation
in response to LPS by 24 h.
Several clusters featured down-regulated trends throughout the
LPS time-course (Fig. 3b). Clusters Nine (n= 44), Ten (n= 10)
and Eleven (n= 34) were functionally associated with the GOBP
terms “chromosome organisation”, “sister chromatid segregation”
and “cellular respiration”, respectively, reinforcing the observa-
tion that DNA replication and cell proliferation were reduced
during the progression of the time-course. The terms “RNA
splicing” and “cellular response to stress” were overrepresented in
Cluster 13 (n= 37) and Cluster 14 (n= 105), while
“oxidation–reduction process” was the top-scoring GOBP term
for Cluster 17 (n= 76) (Fig. 3c).
The hyperLOPIT spatial proteomics platform allows sub-
cellular interrogation of the THP-1 proteome at 0 h
(untreated) vs. 12 h LPS exposure. The time-course of LPS sti-
mulation provides a holistic overview of protein expression in the
THP-1 proteome during the initial phases of a pro-inflammatory
response. By understanding protein relocalisation events, we gain
a more complete picture of the cellular response to LPS. The 0
and 12 h LPS time-points were selected for deeper, spatial pro-
teomics analysis of dynamic trans/relocalisation events occurring
between subcellular regions (where 0 h represents untreated cells).
These time points allow us to compare LPS effects in cells that
had undergone substantial proteomic changes whilst retaining a
non-adherent phenotype.
Three replicate experiments for untreated (0 h-LPS) and also for
stimulated (12 h-LPS) THP-1 cells were performed according to the
established hyperLOPIT methodology. The resulting spatial pro-
teome maps consisted of 3882 and 4067 proteins reliably identified
across all three replicates in the 0 h-LPS and 12 h-LPS conditions,
respectively (Supplementary Data 5, Supplementary Fig. 1b, c). A
subset of 3288 proteins was common across both conditions
(Supplementary Data 6, Supplementary Fig. 1d), of which 78.5%
were also identified in the unfractionated time-course experiment,
providing both temporal and spatial data for 2581 proteins
(Supplementary Fig. 1e). Single time-point spatial information is
also available for proteins that demonstrated dramatic changes in
expression, such as PDCD4, the most significantly down-regulated
protein in the time-course, which was only found in the unstimulated
hyperLOPIT condition. In contrast, IFIT1 and EPSTI1, two of the
most significantly upregulated proteins, were only identified in the
LPS-stimulated dataset. Furthermore, four pro-inflammatory cyto-
kines shown to be secreted after LPS stimulation (IL8, IL1B, CXCL10,
TNF) were identified with low abundance in the 12 h-LPS stimulated
hyperLOPIT dataset and were absent in the 0 h-LPS data
(Supplementary Fig. 1f).
TAGM classification integrates subcellular localisation and the
dynamic response to LPS stimulation. A T-Augmented Gaus-
sian Mixture Model with Bayesian computation performed
using Markov Chain Monte Carlo (TAGM-MCMC)38, was used
to confidently assign proteins to distinct subcellular regions and
to capture and quantify the uncertainty in the allocation of
proteins to these compartments. Organelle classification within
the 3288 hyperLOPIT subsets was performed using 783 organelle
marker proteins representing 11 subcellular niches (Fig. 4a,
Supplementary Data 6 and 7). A total of 1717 proteins in the
unstimulated dataset and 1713 proteins in the LPS dataset were
classified to distinct subcellular regions with high confidence
(Fig. 4b, Supplementary Data 6). The remaining proteins were
classified as “unknown” or unannotated locations, due to either
moonlighting proteins existing in mixed locations, trafficking
proteins or uncertainty in discrete localisation. There was a high
degree of correlation between unstimulated and stimulated
datasets, with 61% of the identified proteome sharing the same
organelle localisation in both conditions (75% including proteins
labelled as unknown) (Supplementary Fig. 1g).
The TAGM classification results were confirmed by manual
curation using the UniProtKB database. For example, 91% of
proteins classified to the cytosol contained predicted UniProt
annotations as “cytosol” or “cytoplasm”. Of the total mitochon-
drial proteins, 95% had documented mitochondrial annotations,
reaffirming the accuracy of the TAGM localisations. The
lysosomal compartment contained 188 assignments common to
both conditions, of which 104 were lysosomal resident proteins
and 25 were endosomal. Interestingly, SNAP29, CD93, RAB21
and RAB23 were only associated with lysosomes in the LPS
stimulated condition and are known to play a role in
autophagosome formation, a process which is known to be
underway in macrophages within 24 h of LPS stimulation56.
LPS exposure appears to induce a dynamic alteration in the
plasma membrane (PM). A total of 135 proteins were assigned to
the PM in both conditions, of which 95% had UniProtKB PM
annotations. CD14, the classic co-receptor for LPS, was localised
to the PM in unstimulated conditions, however was no longer
associated with the PM with high probability following stimula-
tion. Although the LOPIT analysis does not indicate that this
protein is undergoing relocalisation at 12 h-LPS (see Supplemen-
tary Fig. 1h), the data does suggest that the receptor may be
decoupled from the plasma membrane at this time-point. This is
not due to a reduction in abundance, as the protein is unaltered at
12 h-LPS and upregulated at 24 h-LPS, in the time series. CD14 is
essential for TLR4-TRIF-mediated IFNs response through
endocytosis of the signalling complex57, which could account
for the loss of CD14 at the PM and the induction of the IFN
response seen in the time-course data.
LPS stimulation results in protein relocalisation events and
reveals a highly dynamic proteome. Based on the combination
of joint posterior and outlier probabilities, protein trans/reloca-
lisation events that occur following LPS stimulation were classi-
fied as four distinct scenarios: (i) Type 1: organelle-to-organelle,
(ii) Type 2: unknown-to-organelle, (iii) Type 3: organelle-to-
unknown, and (iv) Type 4: unclassified proteins that exhibit large
changes in their posterior probability distribution between con-
ditions. For additional stringency and to capture large movements
in probability space, all potential relocalisation events were
ranked according to their proteins natural L2 distance between
their TAGM joint posterior probabilities. A large L2 distance
between probabilities is indicative of proteins that exhibit large
movements in probability space. High confidence movements
were identified for 253 proteins out of the 3288 proteins analysed,
of which 112, 62, 49 and 30 were assigned to Type 1–4 translo-
cation events, respectively (Supplementary Data 8). A literature
search revealed that of these 253 proteins, 92 (36%) had been
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Cluster 17: poly(A) RNA binding
Cluster 14: protein binding
Cluster 13: poly(A) RNA binding
Cluster 11: poly(A) RNA binding
Cluster 10: microtubule binding
Cluster 9: chromatin binding
Cluster 6: Ras GTPase binding
Cluster 5: structural constituent of nuclear pore
Cluster 4: protein binding
Cluster 3: tRNA binding
Cluster 2: TAP binding
Cluster 1: binding
Fig. 3 Bayesian temporal clustering of the LPS time series demonstrates clusters of co-regulated proteins. a Shown are multiple dataset integration
(MDI) profiles for each protein found in 6 representative upregulated and b 6 downregulated clusters from the Bayesian temporal clustering analysis. The
single bold line profile on each plot shows the mean normalised MDI profile and the 0.05 and 0.95 quantiles of each cluster are highlighted by shaded
bands. c Gene Ontology Biological Process (GOBP) d Cellular Component (GOCC) and e Molecular Function (GOMF) annotation term enrichment for the
clusters are shown. X-axis: –log10(adj.p-value). The numbers within the bar charts refer to the number of proteins associated with that term in each cluster.
Source data are provided as a Source Data file.
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Fig. 4 Assignment of proteins to subcellular organelles using TAGM-MCMC semi-supervised classifier for spatial proteomics data. a Shown are the
t-SNE projections of the unstimulated (0 h-LPS) and stimulated (12 h-LPS) hyperLOPIT datasets. 3288 proteins are shown in each plot and coloured by
organelle protein marker classes. Proteins of unknown/unlabelled locations are shown in grey. b Shown is the same t-SNE projections following TAGM-
MCMC classification. c An alluvial plot representing the 253 proteins that are found to move between organelles at 12 h-LPS. The number of proteins that
are found to translocate to and from each subcellular compartment is denoted next to the labelled strata. The colours of organelles are matched to the
hyperLOPIT organelle colour key.
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previously identified as being directly involved in innate immu-
nity and 51 (20%) were linked specifically with the TLR4/LPS
response (Supplementary Data 9). The remaining 160 (64%)
proteins that underwent translocation in response to 12 h-LPS
have not been previously reported to be influenced at the protein
level by TLR4/LPS stimulation. The majority of these proteins are
involved in cytoskeletal remodelling, the endolysosomal system
and nucleo-cytoplasmic shuttling, processes known to be influ-
enced by LPS stimulation. GO annotation enrichment analysis
confirmed that protein localisation (GO:0008104~protein locali-
sation) and transport (GO:0015031~protein transport) are highly
significant functional processes for this group of 253 relocalising
proteins (see Supplementary Data 11).
The effect of LPS stimulation on protein localisation is variable
across subcellular compartments. By plotting the 253 LPS-
induced relocalisation events onto the hyperLOPIT t-SNE pro-
jections, it became clear that these proteins were distributed
throughout all subcellular compartments (Supplementary
Fig. 2a). The dynamic proteome with the directionality of
movement can be represented on an alluvial plot (Fig. 4c).
Many translocation events occurred in the cytosol for example,
with 67 proteins found to be entering (5/67) or leaving (62/67)
this compartment (Fig. 4c, Supplementary Fig. 2b). Overall, 11%
of all classified cytosolic proteins were found to change location
after LPS stimulation. Proteins were found to move from the
cytosol to either the nucleus (35 proteins) or the PM (8 proteins),
with a further 19 moving to an unclassified location. Only five
proteins were found to become cytosolic after 12 h of LPS
stimulation.
Substantial changes in the proteome composition were also
identified in the nucleus and lysosome (Supplementary Fig. 2c, d)
with 57 and 49 translocators, respectively. Our analysis also
revealed a dynamic regulation of the endomembrane system
following LPS stimulation, with 41 proteins in the process of
being shuttled between the ER, Golgi apparatus, lysosome and
unknown compartments. Conversely, the mitochondria proved to
be a relatively stable organelle at 12 h-LPS, with only 23 proteins
undergoing mitochondrial import or export, corresponding to
4.5% of all mitochondrial assignments. The hyperLOPIT analysis,
therefore, provided evidence of a highly dynamic proteome,
which affects each subcellular compartment differently. A
selection of these translocation events is highlighted below.
Nucleo-cytoplasmic shuttling plays a role in LPS-induced sig-
nalling. Thirty-five proteins were found to translocate from the
cytosol to the nucleus, whereas only two proteins moved from the
nucleus (TRAF2) or the chromatin (DENND4B) to the cytosol.
The cytosol-to-nucleus group contained a nuclear importin
(KPNA2), nuclear exportin (XPO5) and nucleolin (NCL), which
can play a role in nucleocytoplasmic transport of newly synthe-
sised pre-RNAs, as well as 11 subunits of the eukaryotic trans-
lation initiation factor 3 (EIF3) complex and 4 members of the
EIF4 complex (Supplementary Fig. 3a). These complexes mediate
the recruitment of ribosomes to mRNA.
The hyperLOPIT data was sufficiently well-resolved to identify
9 sub-organellar relocalisation events within the nucleus
(Supplementary Fig. 3b) (1 nucleolus-to-nucleus and 8 chroma-
tin-to-nucleus). We observed the relocalisation of CTDSPL2 from
the chromatin to the nuclear cluster following LPS stimulation.
CTDSPL2 can be released from transcriptionally silenced
chromosomal regions during erythroid differentiation58 and it
has been associated with a number of processes identified in this
study, including cellular adhesion, metabolism and protection
from oxidative stress-induced apoptosis.
LPS stimulation results in protein reorganisation at the PM.
The PM is known to undergo a massive structural reorganisation
during monocyte-to-macrophage polarisation and differentiation.
This region was the most dynamically regulated organelle in the
hyperLOPIT study, with 70 proteins found to translocate to (55/
70) or from (15/70) the PM in response to LPS, accounting for
27% of all the identified PM proteins (Supplementary Fig. 3c).
There was a transfer of proteins between the PM and lysosomal
compartment, with 13 proteins moving from the PM to the
lysosome, and 15 travelling in the opposite direction. Among the
lysosome-to-PM group of proteins were several known to be
involved in the LPS/TLR4 response, namely CCR1, SLC38A2,
PSEN2, DAB2 and MSN. This group also included ABHD17A, a
depalmitoylase involved in the dynamic regulation of protein
localisation and signalling59 and RNF167, a trafficking, endocytic
E3 ubiquitin-ligase which regulates lysosomal exocytosis and PM
resealing60.
Of the eight proteins which translocated from the cytosol to the
PM at 12 h-LPS, five have been reported to be involved in LPS/
TLR4 regulation, including CLIC4 which associates with pro-
inflammatory cytokine secretion following LPS stimulation61 and
translocates from the cytosol to the PM in murine macrophages
exposed to LPS62, and HGS, which plays an important role in the
initial steps of TLR4 sorting to the endosomal pathway following
engagement of LPS63. Other proteins in this group, such as
CDC42, are discussed below.
Induction of autophagosome formation and activation of
lysosomal degradation pathways are apparent at 12 h LPS.
Autophagy machinery can be recruited to the site of the phago-
phore following stimulation, where it initiates the formation of
the autophagosome, which subsequently fuses with the lysosomes
to form autophagolysosomes. Autophagy receptors sequestosome
(SQSTM1/P62) and CALCOCO2 (NDP52), as well as TOM1, an
endosomal protein and binding partner of CALCOCO2, undergo
LPS-induced translocation to the PM. We observed that TOM1,
SQSTM1 and CALCOCO2 co-localise in both unstimulated and
stimulated datasets suggesting they may be moving together as a
complex (Supplementary Fig. 3d). TOM1 has been shown to
interact directly with another endosomal trafficking molecule,
TOLLIP64, which moves from the cytosol to the PM in
hyperLOPIT.
The scavenger receptor class B member 1 (SCARB1) and
LRCH4 both relocate from the PM to the lysosome. SCARB1 was
shown to protect against sepsis by promoting LPS clearance in
hepatic cells65 and to suppress TLR4-LPS signalling in mouse
macrophages66. LRCH4 has recently been identified as a TLR4
accessory protein with a role in the regulation of the early phase
of the innate immune response to LPS, by promoting the docking
and delivery of LPS to the lipid raft membranes in the vicinity of
CD1467.
Evidence of relocalisation of Rho-GTPases after 12 h LPS sti-
mulation. Cytoskeletal alterations are apparent at the subcellular
level by 12 h-LPS, with the movement of a number of key
intracellular cytoskeletal regulators such as the Rho-GTPase
family members CDC42, RAC1, RHOA, and RHOC (Fig. 5a, b).
Confocal microscopy demonstrated that CDC42 undergoes a
redistribution from a diffuse cytoplasmic location to punctate
spots in the cell periphery (Fig. 5d) despite being unchanged in
protein abundance (Fig. 5c). Previous studies have shown that
CDC4268, RHOA69 and RAC170 undergo LPS-induced GDP-
GTP exchange and activation. Additional Rho-GTPase-accessory
proteins were also observed to translocate to the PM in response
to LPS stimulation (SRGAP2, ARHGAP18, APBB1IP) (Fig. 5a).
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SRGAP2 is recruited during leucocyte attachment to direct cell
polarisation and adhesion71. APBB1IP (RIAM) is a signal trans-
ducer involved in actin cytoskeletal remodelling during
complement-dependent phagocytosis in THP-1 cells, a process
significantly enhanced after LPS stimulation72.
Translocation of vesicular trafficking molecules regulate the
intracellular response to LPS. The hyperLOPIT analysis identi-
fied the translocation of many vesicular trafficking molecules
(Supplementary Fig. 4a), including the synaptic vesicle glyco-
protein 2A (SV2A), the trafficking protein TRAPPC3, the
clathrin-associated AP-1 complex subunit gamma (AP1G1), the
WASH complex subunit strumpellin and the endosomal charged
multivesicular body protein (CHMP2B). CHMP2B is a member
of the ESCRT-III complex (endosomal sorting complex required
for transport) and moved from an unknown location to the
lysosome. Several other members of the ESCRT-III complex co-
localised with CHMP2B in the lysosome of the LPS-stimulated
condition (Supplementary Fig. 4c), although they did not meet
the threshold to qualify as movers. Furthermore, IST1, which
moved from the cytosol to an unannotated location, is also











































































Fig. 5 Relocalisation of RHO-GTPase trafficking molecules to the PM. Relocalisation of RHO-GTPase family members and accessory proteins were found
in response to LPS, including CDC42, RAC1, RHOA, RHOC, SRGAP2, ARHGAP18, APBB1IP. These proteins are shown in a unstimulated and b LPS-
stimulated conditions. c Western blot of CDC42 in the 24 h-LPS time-course. Anti-actin western blot is shown as control. Molecular weight markers are
indicated in kilodaltons (kDa). d Confocal image (×63) of THP-1 cells ± LPS for 12 h and labelled with anti-CDC42 (Green) and phalloidin (Red). Scale
bar= 10 µm. All western blots and images were conducted at n= 1. Source data are provided as a Source Data file.
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sites of ER-endosomal contact, but did not localise with the
CHMP2B complex. SYTL4 and SCAMP2 underwent relocalisa-
tion from the PM to the lysosome, both of which are involved in
recycling secretory vesicles and granular exocytosis.
The RAB family of small GTPases act as master regulators of
vesicular trafficking and modulators of the immune response. The
hyperLOPIT analysis revealed relocalisation of 12 RABs (Supple-
mentary Fig. 4b), eight of which translocated to the ER, possibly
reflecting a role in antigen presentation or trafficking of newly
synthesised molecules. RAB23, which has previously been shown
to facilitate phagolysosomal fusion73, moved from the PM to the
lysosome, whereas RAB6B moved from the lysosome to the PM.
Several of these RAB traffickers are known to be associated with
the LPS/TLR4 immune response (Supplementary Data 9) and
others are involved in autophagosome formation, including RAB7
and RAB32.
Several proteins undergo both spatial and temporal modula-
tion in response to LPS. Of the hundreds of proteins which were
altered during either the 24 h-LPS time-course or the hyperLO-
PIT analysis, only 15 proteins were found to change both their
location (at 12 h) and their total protein abundance level in
response to LPS over the 24 h time period (Fig. 6a, b, e). Of these,
only the autophagy receptor SQSTM1 and CLEC11A were
changed in abundance at the 12 h-LPS time-point. SQSTM1
became more abundant (Fig. 6c) and also trafficked to the PM.
This multifunctional autophagy receptor is known to be upre-
gulated by LPS74. Meanwhile, CLEC11A became less abundant
(Fig. 6d) and relocated from the lysosome to the ER. We postulate
that the reduced expression of CLEC11A, together with it being
trafficked through the endomembrane pathway, may indicate that
this cytokine molecule is actively secreted from THP-1 cells
during LPS stimulation. This data indicates that distinct reloca-
lisation events and abundance changes are both involved in the
global, cellular response to LPS.
HyperLOPIT provides a scaffold to visualise and interrogate
proteins of interest. Having established that hyperLOPIT pro-
vides a means to robustly classify unannotated proteins to distinct
organelles and to investigate protein relocalisation events, we next
interrogated the THP-1 hyperLOPIT dataset for visualisation of
(i) Bayesian temporal clusters, (ii) protein complexes, (iii)
protein–protein interaction partners, and (iv) specific sub-
proteome populations identified in existing publicly available
datasets.
Three clusters from the Bayesian temporal clustering analysis
of the LPS time-course experiment were overlaid onto the
hyperLOPIT spatial maps (Fig. 7a) revealing that temporal
clusters can be spatially distributed and highly enriched within
certain organelles. Clusters 9, 11 and 17 were enriched in the
hyperLOPIT chromatin, mitochondria and cytosol, respectively.
Protein complexes are well preserved during the hyperLOPIT
procedure (Fig. 7b), including the exocyst complex, actin-related
protein 2/3 complex, coatomer proteins and the DNA replication
licensing MCM complex. Furthermore, entire complexes were
found to relocalise in response to LPS stimulation, as seen by the
EIF3 complex which translocated from the cytosol into the
nucleus (Fig. 7b, Supplementary Fig. 3a).
Protein–protein interaction partners are also preserved during
the hyperLOPIT protocol (Fig. 7c). For example, we see co-
localisation of (i) CDC42 and TRIP10 (CDC42-interacting
protein 4)75, (ii) the endocytic molecules HGS and TSG10176
and (iii) the mitochondrial NLRX1 and FASTKD577. Proteins
known to co-localise upon LPS stimulation were also shown
together in hyperLOPIT space, including IKBKG (Nemo) with
IKBKB78. The LPS-responsive interactors PARP9 and DTX3L41
were both upregulated in abundance by 12 h-LPS and co-localised
in hyperLOPIT space. Likewise, the interferon-inducible binding
partners IFI35 and NMI42 were co-localised and upregulated
following LPS stimulation at 24h-LPS.
Finally, we used the hyperLOPIT dataset as a scaffold to
examine additional spatial protein information identified in
complementary proteomics studies. A secretome analysis of LPS-
activated murine macrophages79 was found to predominantly
localise to the endomembrane secretory pathway in hyperLOPIT
(Supplementary Fig. 5a). Similarly, a cell surface proteome study
of THP-1 cells during differentiation into macrophage-like cells11
maps closely to the PM cluster of hyperLOPIT (Supplementary
Fig. 5b). A macrophage-derived RNA-binding protein (RBP)
interactome80 was enriched in hyperLOPIT nuclear, nucleolar,
ribosomal, and cytosol locations (Supplementary Fig. 5c). A
recent study which isolated the lysosomal and mitochondrial
fractions from murine macrophages was found to overlap with
the hyperLOPIT mitochondrial and lysosomal locations81
(Supplementary Fig. 5d). Together, these results demonstrate
that the hyperLOPIT approach can be used as a platform to
overlay multiple layers of spatial proteomic information in order
to gain a complete global perspective on highly complex cellular
processes.
Discussion
The integrated proteomic analysis presented here has demon-
strated that the pro-inflammatory innate immune response to
LPS in the THP-1 monocytic cell line is regulated by both protein
expression changes and subcellular relocalisation events. Com-
bining temporal abundance profiling, hyperLOPIT spatial pro-
teomics, and a state-of-the-art Bayesian analysis framework, we
infer dynamic protein events within and between organelles
during the LPS immune response. This study provides robust,
quantitative, temporal data for 4292 proteins across a 24 h time-
course of LPS stimulation, as well as the subcellular localisation of
3288 proteins in unstimulated and 12 h-LPS, stimulated condi-
tions. This analysis has revealed the translocation (253 proteins)
and altered abundance (311 proteins) of hundreds of proteins in
response to LPS distributed across different subcellular com-
partments, with only 15 proteins undergoing changes in both
abundance and location. Many of the proteins identified in this
study are known to be involved in immune-related functional
processes including a pro-inflammatory IFN response, PM reor-
ganisation, autophagosomal induction, endolysosomal trafficking,
cytoskeletal remodelling, and nucleocytoplasmic shuttling. Fur-
thermore, several proteins presented here have never been asso-
ciated with the proinflammatory response and may represent
novel targets for therapeutic intervention. This spatial proteomics
study represents the most extensive insight into the LPS-driven
innate immune response reported to date, allowing the simulta-
neous localisation of thousands of proteins undergoing pertur-
bation in a complex and dynamic system.
A cross-comparison of publicly available datasets shows that
many LPS-regulated proteins in different cell types and condi-
tions exhibit the same trend in our time-course quantitative
abundance dataset (Supplementary Data 10) as well as in the
hyperLOPIT list of translocating proteins (Supplementary
Data 9), thereby validating many of our findings presented here.
A number of previous studies have utilised various proteomics
approaches to explore the LPS-induced innate immune response
in macrophages9,10,82,83, as well as to characterise individual
subcellular organelles following LPS activation11,12. This study
presents a global analysis to simultaneously track thousands of
native proteins in response to LPS with a spatial context. Of note,
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the interpretation of the exact mechanisms that underlie the
observed relocalisation of proteins in our study is outside the
scope of this study. It is not possible to distinguish trafficking of
existing proteins from one location to another, from proteins
being differentially degraded at one location and newly synthe-
sised proteins locating to an alternate location. The time frames of
our LPS treatment would enable both of the scenarios to occur.
We believe our data shows that observed ‘movers’ are functionally
in different locations upon LPS treatment compared with
untreated cells.
The field of spatial proteomics is rapidly developing and many
powerful MS-based technologies now exist to provide insights
into the investigation of organelle remodelling, controlled
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localisation in multiple model systems (reviewed in refs. 13,14).
The hyperLOPIT platform and its derivative LOPIT-DC have
now been applied to multiple biological contexts and
questions21,22,24,25,27,28. We present here the first iteration of
dynamic-hyperLOPIT for characterisation of protein relocalisa-
tion events during cellular perturbation using the THP-1
monocytic cell line which is notoriously difficult to use for
microscopy imaging. We have shown that the LPS/TLR4 innate
immune response in the THP-1 cell line is regulated both spa-
tially and temporally. By releasing the hyperLOPIT dataset as an
interactive resource for the scientific community, the data can be
mined for individual proteins, biological complexes, pathways of
interest, or interrogated with other publicly available datasets.
Obtaining a greater understanding of the immune response to
LPS will provide the opportunity to develop strategies in immune
manipulation, which will be of benefit in the development of
vaccines, anticancer therapies and disease treatments.
Methods
Cell culture and LPS stimulation. THP-1 cells (ATCC® TIB-202™) were cultured
in RPMI 1640 medium with GlutaMAX™ (Gibco), supplemented with 10% foetal
bovine serum (Sigma), 100 U/mL of Penicillin and 100 μg/mL Streptomycin
(Gibco), 20 mM HEPES solution (Sigma), and 20 nM 2-mercaptoethanol (Gibco),
under 5% CO2 at 37 °C with a water vapour saturated atmosphere. Cell cultures
were maintained at a density of 0.2–1 × 106 cells/mL.
ELISA. THP-1 cells (9 × 104) were seeded in flat-bottomed 96-well plates with/
without 200 ng/mL LPS (Enzo) and incubated for 2, 4, 6, 12, and 24 h. Following
treatment, plates were centrifuged at 130 × g for 5 min at room temperature to
pellet cells. Supernatants were transferred to new 96-well plates and stored at
−80 °C. ELISA kits for IL-1β (BioLegend, Max Deluxe Set Human), TNFα (Bio-
Legend, Max Deluxe Set Human), IL-6 (BioLegend, Max Deluxe Set Human),
CXCL10 (R&D Systems, Human DuoSet), and IL-8 (R&D Systems, Human
DuoSet) were performed following manufacturer’s instructions using Nunc Max-
iSorp 96 well flat-bottomed ELISA plates (Thermo Fisher Scientific). Supernatants
were prepared in the appropriate reagent diluent using the following dilution
factor: IL-1β, neat; TNFα, 1:15; IL-6, 1:5; CXCL10, 1:5; and IL-8, 1:20. ELISA plates
were read on a CLARIOstar microplate reader (BMG LABTECH), with cytokine
concentrations extrapolated using the MARS Data Analysis Software (BMG
LABTECH).
Immunoblotting. THP-1 cells (2 × 106) were seeded in six-well plates with/without
200 ng/mL LPS and incubated for 2, 4, 6, 12, and 24 h. Cells were lysed in RIPA
buffer (150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1%
SDS, 50 mM Tris, pH 8.0; Sigma) containing 2 × Halt Protease and Phosphatase
Inhibitor Cocktail (Thermo Fisher Scientific) for 10 min on ice. Cell lysates were
centrifuged at 16,000 × g for 10 min at 4 °C, with supernatants aliquoted into
1.5 mL microcentrifuge tubes and stored at −80 °C. Protein was quantified using
the DC Protein Assay Kit II (BioRad), following the manufacturer’s instructions.
Cell lysates (20 μg/lane) were separated on SDS–PAGE gels and transferred onto
PVDF membranes (Amersham Hybond P 0.2 μm, GE Healthcare). Membranes
were blocked in 1× Casein Blocking Buffer (Sigma) in phosphate buffered saline-
Tween-20 (PBS-T) (137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1.5 mM KH2PO4,
0.1% v/v Tween-20) for 1 h at room temperature with gentle agitation and then
probed with primary antibodies overnight at 4 °C in blocking buffer with gentle
agitation. The blots were then probed with rabbit anti-SQSTM1 (1:2000; Cell
Signalling, Cat #: 5114), mouse anti-CLEC11a (1:1000; R&D Systems, Cat #:
MAB1904), rabbit anti-cdc42 (1:500; Proteintech, Cat #: 10155-1-AP), rabbit anti-
IL-1β (1:5000; Cell Signalling, Cat #: 12703), and rabbit anti-actin (1:5000; Sigma,
Cat #: A2066) antibodies overnight at 4 °C in blocking buffer with gentle agitation.
Following 3 × 15 min washes with PBS-T, membranes were probed with polyclonal
goat anti-rabbit IgG-HRP (1:5000;DAKO, Cat #: P0448) or polyclonal goat anti-
mouse HRP (1:5000; DAKO, Cat #: P0447) as appropriate, in blocking buffer for
1 h at room temperature with gentle agitation. After a further 3 × 15 min washes
with PBS-T, bound antibody was detected using Immobilon Western Chemilu-
minescent HRP substrate (Millipore), and either exposed to Amersham Hyperfilm
ECL (GE Healthcare) or visualised using a myECL Imager (Thermo Fisher
Scientific).
Immunocytochemistry. THP-1 cells at a density of 8 × 105 cells/mL were cultured
with/without 200 ng/mL LPS and incubated for 2, 4, 6, 12, and 24 h. THP-1 cells
were pelleted at 130 × g for 5 min at room temperature followed by one wash with
warm PBS containing magnesium and calcium (Gibco). After pelleting as before,
cells were fixed in 4% methanol-free formaldehyde in PBS for 20min at room
temperature. Cells were pelleted by centrifugation at 130 × g for 5 min and washed
with PBS three times and then resuspended in PBS containing 0.02% sodium azide
and stored at 4 °C. Fixed cells (5 ×1 04) were spun onto Plus+ Frost Positive
Charged microslides (Solmedia) at 800 rpm for 3 min in a cytocentrifuge (Cytospin
2, Shandon). The attached cells were covered with PBS and circumscribed using a
hydrophobic barrier pen (ImmEdge Pen, Vector Labs). Following preincubation
with 1× Perm/Wash solution (BD Biosciences) for 15min at room temperature,
cells fixed with formaldehyde were incubated with 0.01% v/v Triton X-100 in PBS
for 5 min followed by 3 × 5min washes with 1× Perm/Wash solution. Cells were
blocked with 10% normal goat serum (NGS, Bio-RAD), 0.1 mg/mL human IgG
(Vivaglobin, CSL Behring) in 1× Perm/Wash solution for 1 h at room temperature.
Formaldehyde-fixed cells were incubated with rabbit anti-cdc42 (1:150; Proteintech,
Cat #: 10155-1-AP) in 5% NGS in 1× Perm/Wash solution overnight at 4 °C.
Following 3 × 5 min washes with 1× Perm/Wash Solution, cells were incubated
with goat anti-Rabbit IgG (H+ L) Cross-Adsorbed Secondary Antibody, Alexa
Fluor 488® (2 μg/mL; Thermo Fisher Scientific, Cat #: A-11008), and Alexa Fluor®
546 dye-conjugated Phalloidin (2 U/mL; Thermo Fisher Scientific, Cat #: A22283),
in 5% NGS in 1× Perm/ Wash solution for 1 h at room temperature. After 3 × 5min
washes with 1× Perm/Wash solution, cells were incubated with 0.1 μg/mL DAPI in
PBS for 15 min at room temperature, followed by a further 3 × 5 min washes with
1× Perm/Wash Solution. Glass coverslips (No 1.5 thickness, VWR) were mounted
over stained cells with ProLong Glass Antifade Mountant (Thermo Fisher Scien-
tific). Images were captured using a Leica SP5 confocal microscope at ×63 magni-
fication. Fiji software was used for image processing.
Cell lysate preparation for time-course analysis. THP-1 cells (106) were sti-
mulated with 200 ng/mL LPS (Salmonella abortus equi S-form (TLRGRADE™),
Enzo) and lysed at appropriate time-points (0, 2, 4, 6, 12, 24 h) in lysis buffer
containing 0.2% SDS, 50 mM HEPES pH 7.4 with protease inhibitors (Roche).
Benzonase nuclease at a concentration of 25 U/mL (Sigma) was added and incu-
bated for 30 min, on ice. Samples were sonicated for 3 × 5 min bursts in a cooled
sonicating bath (Bioruptor, Diagenode), to aid solubilisation and then centrifuged
at 16,000 × g, 10 min, 4 °C to remove insoluble material. The supernatant con-
taining the cell lysate was aliquoted into new tubes and stored at −80 °C. Three
biological triplicate time-course experiments were conducted.
Subcellular fractionation for hyperLOPIT. Equilibrium density gradient ultra-
centrifugation is central to the hyperLOPIT protocol and is described in ref. 26.
Briefly, Iodixanol Working solution (IWS) was prepared by dilution of Optiprep™
Density Gradient Medium (60% (w/v) iodixanol, Sigma) to a working concentra-
tion of 50% with 6× lysis buffer (60 mM HEPES pH 7.4, 12 mM EDTA pH 8.0,
12 mM magnesium acetate) containing protease inhibitors. A range of iodixanol-
containing solutions were prepared by dilution of the IWS to 6%, 8%, 12%, 16%,
20% and 25% (w/v) iodixanol.
5 × 108 THP-1 cells (either unstimulated or following 12 h of 200 ng/mL LPS
stimulation) were harvested by centrifugation, washed several times in PBS and
resuspended in 20 mL iso-osmotic detergent-free lysis buffer at an approximate
concentration of 2.5 × 107 cells/mL (detergent-free lysis buffer: 0.25M sucrose,
10 mM HEPES pH 7.4, 2 mM EDTA pH 8.0, 2 mM magnesium acetate, with
protease inhibitors). Cell lysis was achieved by passing 1 mL aliquots of the cell
suspension through a ball-bearing homogeniser (Isobiotec) with 12 µm clearance,
on ice. The efficiency of cell lysis was monitored by Trypan blue exclusion staining
and light microscopy. The combined cell lysate was incubated with 25 U/mL
Fig. 6 Proteins can exhibit both spatial and temporal regulation by LPS. 15 proteins were altered in abundance during the time-course of LPS stimulation
and also translocated to different subcellular regions. The distribution of these 15 proteins in hyperLOPIT space is shown for a the unstimulated and b the
LPS-stimulated conditions. c Western blot and the median TMT reporter ion quantitation (red) for SQSTM1 in the 24 h-LPS time-course. Anti-actin
western blot is shown as control. Molecular weight markers are indicated in kilodaltons (kDa). The immunoblot in Fig. 2e was stripped and re-probed for
anti-SQSTM1. The same actin blot was therefore also used as a loading control. d Western blot and proteomic quantitation (blue) for CLEC11A in the 24 h-
LPS time-course. Anti-actin western blot is shown as control. Molecular weight markers are indicated in kilodaltons (kDa). e A heatmap of the relative
quantitative abundance values for these 15 proteins during the time-course experiment. All western blots were conducted at n= 1 and temporal proteomics
at n= 3 biologically independent experiments. Source data are provided as a Source Data file.
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a 
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Cluster 9        Chromatin        6.39e-10     1.43e-10
Cluster 11      Mitochondria     9.59e-09       7.7e-08
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Fig. 7 The hyperLOPIT dataset can be used as a scaffold to overlay additional layers of spatial information. a Three temporal clusters from the Bayesian
temporal clustering analysis (cluster numbers 9 (purple), 11 (yellow) and 17 (cyan)) were overlaid onto a t-SNE projection of the hyperLOPIT data. A
Fisher’s exact test was used to determine that these three clusters were enriched for individual hyperLOPIT organelles (p-values were adjusted using a
Benjamini–Hochberg correction). The temporal profiles of the three Bayesian temporal clusters during the 24 h-LPS time-course are also shown. A single
bold line on each profile plot shows the mean normalised MDI profile and the 0.05 and 0.95 quantiles of each cluster is highlighted by shaded bands. b
Several protein complexes were overlaid onto the hyperLOPIT plot. c Protein–protein interaction partner pairs from the literature were shown to co-localise
with each other in hyperLOPIT space. Source data are provided as a Source Data file.
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Benzonase nuclease (Sigma) for 30 min, on ice and insoluble cell debris was
removed by centrifugation at 200 × g, 5 min, 4 °C, which was repeated three times.
The lysate solution was underlaid with 6% and 25% (w/v) iodixanol solutions and
ultracentrifuged at 100,000 × g, 90 min, 4 °C (SW32Ti swinging bucket rotor; Optima
L-80 XP Beckman ultracentrifuge). An aliquot of the supernatant taken from above
the membrane cushion was diluted 10-fold with chilled acetone for 24 h and then
precipitated from the acetone solution at 16,000 × g, 30 min, 4 °C, air-dried and stored
at −20 °C. The crude membranes from the cushion interface were diluted 5-fold with
lysis buffer and ultracentrifuged at 200,000 × g, 60min, 4 °C. Two linear
discontinuous gradients were prepared by layering 8%, 12%, 20% and 25% (w/v)
iodixanol solutions into 11mL capacity polyallomer OptiSeal™ ultracentrifuge tubes
(Beckman). The gradient was allowed to diffuse for several hours at 4 °C to perform a
continuous density gradient, during which time the crude membranes were prepared.
The crude membrane pellet was resuspended gently in a final volume of 2.2mL of
25% iodixanol solution and underlaid beneath the iodixanol density gradient, using a
wide-bore needle. Ultracentrifugation was performed at 100,000 × g for 10 h, 4 °C
(NVT65 fixed-angle near-vertical rotor; Optima L-80 XP Beckman ultracentrifuge)
with minimum deceleration. Subcellular fractions were collected using an Auto-Densi
Flow peristaltic pump fraction collector with a meniscus-tracking probe (Labconco).
The refractive index of each fraction was determined with a hand-held refractometer
(Reichert). Membrane proteins were pelleted from the iodixanol fractions by 3-fold
dilution in lysis buffer supplemented with protease inhibitors and ultracentrifugation
at 100,000 × g, 60 min at 4 °C (TLA-55 rotor; Optima Max-XP benchtop
ultracentrifuge, Beckman). This wash step was repeated three times for each fraction,
the buffer was removed and the resulting membrane pellets were stored at −80 °C for
no longer than one month.
Proteolytic digestion, TMT labelling and peptide fractionation by UPLC. All
hyperLOPIT fractions were resuspended in urea solubilisation buffer (8 M urea,
0.15% SDS, 25 mM HEPES, pH 8.0), sonicated briefly to aid solubilisation and the
protein concentrations were determined using the BCA protein assay (Thermo
Fisher Scientific). 50 μg of each membrane sample was labelled with a distinct
TMT tag, disulfide bonds were reduced by the addition of 10 mM dithiothreitol
(DTT) for 1 h at 37 °C, followed by alkylation of free cysteine residues with 25 mM
iodoacetamide (IAA) for 2 h at room temperature in the dark. Each sample was
then precipitated overnight with 10 volumes of cold acetone at −20 °C. Samples
were centrifuged at 16,000 × g, 20 min, 4 °C, the protein pellets were washed with
90% acetone, centrifuged again and finally air-dried for no longer than 15 min.
Each sample was resuspended in 0.5 mL of 50 mM HEPES, pH 8.5, sonicated
briefly at 4 °C to aid resolubilisation and proteolytically digested with sequencing
grade porcine trypsin (Promega) at a final enzyme:protein ratio of 1:20, overnight
at 37 °C. Samples were reduced to 0.1 mL in a refrigerated SpeedVac vacuum
centrifuge with a cold trap (Labconco).
TMT labelling was conducted as described previously26. Amine-reactive 10plex
tandem mass tags (TMT, Thermo Fisher Scientific) were equilibrated to room
temperature and resuspended in 41 μL LC–MS grade acetonitrile. The peptide-
containing samples were added to the appropriate tag vial and labelling was
allowed to proceed for 3 h at room temperature on a shaker. The reactions were
quenched with 5% (w/v) hydroxylamine solution for 30 min, following which the
10 samples corresponding to each 10plex were pooled together and reduced to
dryness by refrigerated vacuum centrifugation. The pooled 10plex sample was then
desalted using C18 solid-phase SepPak cartridges (100 mg bed volume, Waters).
Twenty fractions including the cytosol-enriched fraction were labelled per gradient,
by combining two TMT 10plex experiments in an interleaved labelling design to
capture as much subcellular diversity as possible. Therefore, two separate MS runs
were conducted for each biological replicate experiment.
The desalted TMT-labelled peptide samples were resuspended in 20 mM
ammonium formate, pH 10.0 for high pH reversed-phase UPLC on the Acquity
chromatography system with a diode array detector (Waters). Peptides were
separated on an Acquity UPLC BEH C18 column (bridged ethyl hybrid C18
column, 2.1 mm i.d. × 150 mm; 1.7 µM particle size, Waters) using acetonitrile
(ACN)/ammonium formate (pH 10.0) gradient. MassLynx software (version 4.1)
method parameters: 0.0 min: 95% A/5% B; 10.0 min: 95% A/5% B; 60.0 min: 25%
A/75% B; 62.0 min: 0% A/100% B; 67.5 min: 0% A/100% B; 67.6 min: 95% A/5% B.
Total run time was 75 min, flow rate was set to 0.244 mL/min. Buffer A: 20 mM
ammonium formate, pH 10.0; Buffer B: 20 mM ammonium formate, pH
10.0+ 80% (v/v) ACN. Forty fractions were collected across 1 min intervals during
peak peptide elution, while monitoring the chromatographic performance with the
diode array detector (210–400 nm). The eluted TMT-labelled peptide fractions
were dried by vacuum centrifugation and stored until MS analysis. Prior to MS
analysis, the 40 fractions were orthogonally combined into 20 fractions by
combining fractions which eluted at different points of the UPLC gradient.
For the LPS time-course analysis, 50 µg of each lysate was taken for TMT 6-plex
labelling and the volume was made up to 100 µL with 50 mM HEPES, pH 8.0. All
reduction/alkylation, tryptic digestion, TMT labelling, sample clean-up and
desalting with C18 solid-phase extraction, as well as high pH reversed-phase UPLC
were conducted in the same way as described for the hyperLOPIT samples.
Mass spectrometry. The LPS time-course data were acquired on an Orbitrap Q-
Exactive™ MS (Thermo Fisher Scientific) with MS2 level quantitation, while the
hyperLOPIT analysis was acquired on the Orbitrap™ Fusion™ Lumos™ Tribrid™
instrument (Thermo Fisher Scientific) using synchronous precursor selection
(SPS)-MS3 level quantitation. Both instruments were coupled to Dionex Ultimate
3000 RSLCnano systems (Thermo Fisher Scientific).
The TMT-labelled peptide fractions were each resuspended in 0.1% formic acid
(FA) and 1 µg of each fraction was loaded onto a micro-precolumn (C18 PepMap
100, 300 µm i.d. × 5 mm, 5 µm particle size, 100 Å pore size, Thermo Fisher
Scientific) with 0.1% (v/v) formic acid loading solvent for 3 min, before the valve
was switched from load to inject. Peptides were separated on a Proxeon EASY-
Spray column (PepMap, RSLC C18, 50 cm × 75 µm i.d., 2 µm particle size, 100 Å
pore size, Thermo Fisher Scientific) with a 2–40% (v/v) gradient of ACN+ 0.1%
FA, at 300 nL/min for 95 min, followed by wash step (70% ACN+ 0.1% FA, 5 min)
and re-equilibration step, with a total run time of 120 min.
The Orbitrap Q-Exactive™ MS instrument was operated in positive polarity ion
mode with data-dependent MS2 (Top 20) acquisition, where the m/z values for
precursor ions are measured in the Orbitrap (OT) mass analyser at a resolution of
70,000; AGC target: 1e6; scan range 380–1500m/z; profile mode. Fragment ions
were generated by high-energy collisional dissociation (HCD) in the quadrupole
mass analyzer and measured in the OT at a resolution of 17,5000; AGC target: 5e4;
TopN= 20; isolation window: 1.2m/z; collision energy: 32.5%; stepped collision
energy: 10%; profile mode. Peptide ions with charge states of 2+ to 5+ were
selected for fragmentation. A total run time (including washing and re-
equilibration) of 120 min was employed.
The Orbitrap™ Fusion™ Lumos™ Tribrid™ instrument was operated in positive
ion data-dependent mode with an SPS-MS3 acquisition method and a run time of
120 min, as previously described21,24,26. The acquisition workflow parameters for
XCalibur v3.0.63 (Thermo Fisher Scientific) were set up as follows for SPS-MS3 on
the Orbitrap™ Fusion™ Lumos™ Tribrid™ instrument: The full scan was acquired in
the OT at a resolution of 120,000; mass range= normal; quadrupole
isolation= yes; scan range of 380–1500; RF lens 30%; automatic gain control
(AGC) target of 4.0e5; max inject time= 50 ms; microscans= 1, in profile mode
with positive polarity; monoisotopic peak determination= peptide; exclude after n
times= 1; exclusion duration= 70 s; mass tolerance= 10 ppm; exclude
isotopes= yes; include charge state(s): 2–7; perform dependent scan on single
charge state pre precursor only= yes; intensity threshold= 5.0e3. MS2 level
fragmentation occurred in the linear ion trap (IT) with data-dependent
mode= Top Speed (TopS) (ddMS2 IT CID); isolation mode= quadrupole;
isolation window of 0.7m/z; activation type= CID (Collision Induced
Dissociation); collision energy of 35%, Activation Q= 0.25; Ion trap scan
rate= Turbo; AGC target 1.0e4; max inject time= 50 ms; microscans= 1; data
type= centroid; precursor selection range= 400–1200; precursor ion exclusion
width= low 18m/z, high 5m/z; isobaric tag loss exclusion= TMT; precursor
priority=most intense. Synchronous Precursor Selection (SPS) MS3 (ddMS3 OT
HCD) was enabled in the Orbitrap using higher collision dissociation (HCD), a
number of precursors= 10; MS isolation window= 0.7; HCD Collision Energy of
65%; OT resolution of 60,000; scan range of 100–500m/z; AGC target 5e4; max
inject time= 86 ms; microscans= 1; in profile mode. One dataset acquired in
August 2016 contained higher AGC target of 1.0e5 and max inject time= 120 ms.
Data processing. XCalibur.raw files from both the time-course and hyperLOPIT
experiments were processed with Proteome Discoverer v2.1 (Thermo Fisher Sci-
entific) and Mascot server v2.3.02 (Matrix Science). The SwissProt sequence
database for Homo sapiens was downloaded from UniProt (www.uniprot.org) in
November 2016, with 42,118 canonical and isoform sequence entries, together with
48 common contaminants sequences from the cRAP database (common Reposi-
tory for Adventitious Proteins, https://www.thegpm.org/crap).
For the hyperLOPIT analysis, parameters included a 20 ppm reporter ion
integration tolerance window around the expected reporter ion m/z value, 10 ppm
precursor mass tolerance, 0.6 Da fragment mass tolerance, reporter peak intensities
were integrated using the most confident centroid, tryptic digestion was selected as
the enzyme of choice and a maximum of 2 missed cleavages were permitted. Static
modifications: TMT(K), TMT(N-term), carbamidomethyl(C); Dynamic
modifications: oxidation(M), carbamidomethyl(N-term), carbamyl(K), and
deamidation(NQ), as appropriate. Percolator was used to obtain a robust peptide-
spectrum match (PSM) level false discovery rate of 1%. Peptide “rank” must equal
one with a minimum length of six amino acids, only “high confidence” peptides
were used for identification and only unique peptides were used for quantification.
Protein Grouping following strict parsimony was enabled and TMT isotopic
impurity correction factors were applied. For the time-course analysis, the above
parameters were the same, with the exception of the precursor and the fragment
mass tolerances which were set to 20 ppm and 0.2 Da, respectively.
For both the hyperLOPIT and the time-course analyses, the PSM-level data was
extracted using the following parameters: Number of Protein Groups= 1;
Rank= 1; Search Engine Rank= 1; “Isolation Interference” ≤ 50%; “Average
Reporter S/N” ≥ 10; “Peptide Quan Usage”=Used; “Quan Info”=Unique. The
“Ion Score” was set to ≥20.0 for hyperLOPIT and ≥25.0 for time-course analysis.
PSMs corresponding to proteins from the cRAP database, including common
laboratory contaminants and preparative agents, such as porcine trypsin and
keratins, were removed and all PSMs containing >2 missing values in the reporter
ion series were excluded from the analysis. Several PSMs were re-included in the
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final hyperLOPIT dataset because they were robustly identified in 11 out of the 12
individual 10plex experiments, where the “missing” 10plex met the following
“relaxed” criteria: Isolation Interference < 60%; “Average Reporter S/N” > 9.5;
“Search Engine Rank” ≥ 2; “Ion Score” > 19.5. In addition, one TMT channel was
removed from the final hyperLOPIT analysis in both the unstimulated and
stimulated conditions, due to erroneous labelling of insoluble material during the
sample preparation for one replicate. The “Average Reporter S/N” value was
recalculated for the nine remaining channels in this 10plex and PSMs with a value
less than 9.0 were discarded.
The PSM-level dataset used for the final hyperLOPIT and time-course analyses is
openly and freely available in Bioconductor pRolocdata data package (≥v1.27.3)30. All
data analysis and machine learning were conducted using the R33(v3.5.1, http://
www.R-project.org/) Bioconductor (v3.7)31,32 packages MSnbase (v2.8.3)29 and
pRoloc (v1.23.2)30 as per the pRoloc pipeline26,84.
Missing value imputation. A maximum of two missing values per TMT experi-
ment was allowed at the PSM level in both the hyperLOPIT and time-course data.
Missing values were carefully assessed in R and values missing at random were
imputed with the k-Nearest Neighbour algorithm, and values not missing at ran-
dom (e.g. biologically relevant missing values such as those resulting from the
absence of the low abundance of ions) were imputed with a left-censored deter-
ministic minimal value approach using the MSnbase package29. PSMs were quality
controlled post-imputation and then combined to protein level by calculating the
median of all PSM intensities corresponding to the leading UniProt Accession
number for each protein group.
Data normalisation. Following missing value imputation, the time-course repli-
cates were combined and normalised using variance stabilising normalisation
(vsn)85 to account for any technical variation between biological replicate experi-
ments without affecting biological variability (Supplementary Data 1). For the
hyperLOPIT data, the protein profiles were scaled into the same intensity interval
(0 and 1) by dividing each intensity by the sum of the intensities for that quan-
titative feature (sum normalisation), as described in Mulvey et al.26 (Supplementary
Data 5).
Data fusion. 3882 proteins were identified across the three concatenated “unsti-
mulated” hyperLOPIT biological replicates (with a total of 5107, 4838 and 5733
proteins in replicates 1, 2 and 3, respectively), see Supplementary Data 5. 4067
proteins were common across the three “LPS-stimulated” biological replicates (with
a total of 4879, 4866 and 5848 in replicates 1, 2 and 3, respectively), see Supple-
mentary Data 5. These combined datasets for the unstimulated and LPS-stimulated
experiments were used for downstream data analysis as replicate concatenation has
been previously shown to improve dataset resolution21,86 and the ability to identify
genuine residents. These datasets were further subsetted to analyse the proteins
common between both conditions (resulting in 3288 proteins) which were used to
identify translocation events. The unstimulated and the LPS-stimulated-subsets are
found in Supplementary Data 6. All datasets are available in the supporting
information and pRolocdata package30 in Bioconductor.
Marker list generation. A list of well annotated, unambiguous resident organelle
marker proteins from 11 subcellular niches: mitochondria, ER, Golgi apparatus,
lysosome, peroxisome, PM, nucleus, nucleolus, chromatin, ribosome and cytosol,
were curated from the UniProt database87, GO88 and from mining the literature.
Only proteins known to localise to a single location were included as markers. This
marker list is available in Supplementary Data 7 and in pRolocdata.
Protein localisation and re-localisation prediction using a fully Bayesian fra-
mework. A fully Bayesian framework was employed for protein localisation pre-
diction in the R pRoloc package30 using the TAGM-MCMC algorithm38, whereby
the uncertainty in the allocation of proteins to subcellular compartments was
captured and quantified. TAGM-MCMC was used to classify proteins of unknown
location to one of the 11 subcellular niches by assessing the output posterior and
outlier probabilities for each protein. TAGM-MCMC38 is a semi-supervised
Bayesian generative classifier based on a T-Augmented Gaussian Mixture model
(TAGM) that uses Bayesian computation performed using Markov-chain Monte
Carlo (MCMC). For each combined dataset, the collapsed Gibbs sampler was run
in parallel for 9 chains, with each chain run for 25,000 iterations. The Gelman-
Rubin’s diagnostic89 was used to assess the convergence of the 9 Markov-Chains
and the 3 best chains were kept and pooled for data processing for each condition.
A conservative approach was taken, wherein proteins were only assigned to a
subcellular niche if the posterior probability was greater than 0.999 and also if the
outlier probability was very small (<1e−6), else proteins were left unassigned and
labelled as proteins of “unknown location”.
For each protein the predicted localisation was examined in the unstimulated
and the LPS-stimulated dataset and relocalisations were mapped and classified into
one of four different translocation events: (1) from one organelle class in the
unstimulated condition to a different organelle class in the LPS-stimulated dataset
i.e. organelle to organelle, (2) from an unknown localisation in the unstimulated
dataset to a predicted organelle class in the LPS-stimulated dataset i.e. unknown to
organelle, (3) from a predicted localisation in the unstimulated dataset to an
unknown location in the LPS-stimulated dataset i.e. organelle to unknown, and
finally (4) a protein that exhibits a large change between posterior probabilities in
both conditions and did not get assigned a class label by TAGM.
For every protein the natural L2 distance (also known as the Euclidean norm)
was calculated between the TAGM joint posterior probabilities providing an extra
source of information on which to rank proteins of interest. A large L2 distance
implies a large change in probability distribution. The L2 distance is denoted by






where x and y are the posterior probabilities for the unstimulated and 12 h-LPS
stimulated respectively, for each ith class. The L2 distance was used for defining
potential type four translocations where proteins did not meet the criteria to be
assigned to one of the organelle classes in the training data but did exhibit large
changes in their probability distribution as deduced by the L2 value. Only proteins
with the maximum L2 distance of 1 were extracted as type 4 candidates for further
data mining. This small subset comprised of 30 proteins.
Assessing changes in abundance. Limma’s paired moderated t-test (using a
Benjamini–Hochberg90,91 (BH) correction, with a 1% FDR) was used to find sets of
differentially expressed proteins at each time-point92. Proteins were deemed to be
significantly up-regulated or down-regulated if both their adjusted p-value ≤ 0.01
and absolute log2FC ≥ 0.6 (Supplementary Data 1).
Integrative Bayesian model-based clustering with temporal dependencies.
The proteomic expression time-course data were modelled according to a Bayesian
mixture model, where the temporal dependencies were captured using Gaussian
process (GP) regression models with squared exponential covariance functions55,93.
Each component in the mixture model may have had different GP hyperpara-
meters, and standard normal priors were placed on the log of each hyperparameter,
as in ref. 55. The number of clusters in the data were automatically inferred94. As
described by Fritsch and Ickstadt95, a summarised clustering of the data was
produced by first computing the posterior similarity matrix, and then finding the
clustering which maximises the posterior expected adjusted Rand index95. To
assess convergence, two parallel MCMC runs confirmed that the number of
clusters in both parallel runs oscillated around the same mode. Convergence was
further assessed by monitoring the sampled value of the Dirichlet distribution mass
parameter and calculated the Gelman convergence diagnostic96, which was con-
firmed to be <1.2 in all three replicates. The association of clusters from the
temporal analysis with classifications from the spatial analysis using Fisher’s exact
test97 were assessed.
To combine replicate time-series measurements the multiple dataset integration
(MDI) Bayesian correlated clustering model55 was used, which models the
dependencies between clustering structures across datasets. Bayesian inference was
performed using MCMC (see ref. 55 for further details on inference and modelling)
as implemented in the MDI-GPU software98. Clusters were extracted only for
proteins that were consistently allocated to the same clusterings (sampled from the
posterior distribution) across replicates55,99 (Supplementary Data 3).
GO enrichment. Temporal clusters were functionally annotated by using the GO88.
For each cluster in turn, an enrichment test for biological process, cellular com-
partment and molecular function annotations, was carried out using the Database
for Annotation, Visualisation and Integrated Discovery100 (DAVID v6.8; https://
david.ncifcrf.gov/) where a cutoff of <0.05 was applied according to the
Benjamini–Hochberg procedure90. The GO annotation enrichment results are
found in Supplementary Data 4 and 11.
R Shiny app. To enable mining, mapping and visualisation of the data, we provide an
interactive R Shiny Application for the community at http://proteome.shinyapps.io/thp-
lopit/. The app features two interactive and searchable spatial maps of the two LOPIT
experiments for the unstimulated and 12 h-LPS stimulated LOPIT concatenated tri-
plicate experiments. The interactive Shiny app in particular provides a platform for the
community to interrogate the data directly online via their web browser. The app allows
users to visualise the data as annotated t-SNE plots, it supports batch searching, batch
import and export of proteins, complexes and networks of interest within the dataset, as
well as many other features. The app is subdivided into different tabs: (1) Spatial Map,
(2) Profiles, (3) Circos, (4) Table Selection, (5) Table legend, (6) Sample info and (7)
Colour picker. A searchable data table containing the experimental feature meta-data is
permanently displayed at the bottom of the screen for ease and supports batch import
and export of protein information, e.g. accession, gene name, description, etc.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The data is freely available online through (1) the R Bioconductor pRolocdata package
(≥v1.27.3) (https://bioconductor.org/packages/release/data/experiment/html/
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pRolocdata.html), (2) the ProteomeXchange Consortium via the PRIDE (https://
www.ebi.ac.uk/pride/) partner repository101, with the dataset identifier PXD023509 (title:
HyperLOPIT and temporal proteomic profiling of the response to lipopolysaccharide in
the THP-1 human leukaemia cell line) and (3) an interactive R Shiny app hosted at
http://proteome.shinyapps.io/thp-lopit/. Source data are provided with this paper.
Code availability
As detailed in the data processing section of this manuscript XCalibur.raw files from all
proteomic experiments were processed with Proteome Discoverer v2.1 (Thermo Fisher
Scientific) and Mascot server (v2.3.02) (Matrix Science). Quantification to protein-level
abundances from peptide spectrum matching and subsequent protein localisation
analyses was carried out using the freely and openly available R Bioconductor packages
MSnbase (v2.8.3) (http://bioconductor.org/packages/release/bioc/html/MSnbase.html),
pRoloc (v1.23.2) (http://bioconductor.org/packages/release/bioc/html/pRoloc.html) and
pRolocGUI (v2.0.0) (http://bioconductor.org/packages/release/bioc/html/
pRolocGUI.html) as described in hyperLOPIT protocols and workflows in26,85. All R
code used for data analysis and generation of figures is openly and freely available at
https://github.com/CambridgeCentreForProteomics/thp-lopit-2021 102 along with a
vignette (https://cambridgecentreforproteomics.github.io/thp-lopit-2021/).
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